Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Comment by curiousbuildon Sep 14, 2015 3:19pm
121 Views
Post# 24102570

RE:RE:RE:RE:MSL Q3 Conference Call

RE:RE:RE:RE:MSL Q3 Conference Call
mostl likely.. fund and instutional holdings look good on Morningstar but I am not sure about recent holdings.. it appears house 72 has been heavy seller for a long time, may be short or not.. I hope it regrets its decision sooner than later.. short ratio is not high here just  .052% as of Sept 1st..

Additionally, MSL is still postive for 2015 so few names to manage it on TSX and that may be causing selling pressure in this gongshow market conditions..

CB
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse